A phase Ib/II study of gocatamig (MK-6070; HPN328) and ifinatamab deruxtecan for relapsed/refractory extensive-stage small cell lung cancer (ES-SCLC)
  • Bar, J.
  • Montanez, J. C. Benitez
  • Mendivil, A. F. Navarro
  • Gutierrez, M.
  • Johnson, M. L.
  • ... Sun, J-M.
  • 외 14명
Citations

WEB OF SCIENCE

0
제목
A phase Ib/II study of gocatamig (MK-6070; HPN328) and ifinatamab deruxtecan for relapsed/refractory extensive-stage small cell lung cancer (ES-SCLC)
저자
Bar, J.Montanez, J. C. BenitezMendivil, A. F. NavarroGutierrez, M.Johnson, M. L.Caglevic, C.Peled, N.Kutiel, T. ShentzerSands, J.Rojas, C. I.Rocha, P. F. Simoes DaAlgin, E.Udagawa, H.Ariyasu, R.Kim, T. M.Rathi, C.Karantza, V. V.Liu, Q.Gramza, A. W.Sun, J-M.
DOI
10.1016/j.annonc.2025.08.3403
발행일
2025-09
유형
Meeting Abstract
저널명
Annals of Oncology
36